A defined subunit vaccine that protects against vector-borne visceral leishmaniasis

Leishmaniasis: Improved vaccine candidate demonstrates protection A research collaboration between the United States and Bangladesh has improved its own vaccine candidate and demonstrated it to be effective. The vaccine’s target, visceral leishmaniasis, is a deadly parasitic disease transmitted via...

Full description

Bibliographic Details
Main Authors: Malcolm S. Duthie, Lais Pereira, Michelle Favila, Kimberly A. Hofmeyer, S. Jim Reed, Sonia Metangmo, Shannon Townsend, John D. Laurance, Alessandro Picone, Ayesha Misquith, Faria Hossain, Prakash Ghosh, Md Anik Ashfaq Khan, Jeffery Guderian, H. Remy Bailor, Hong Liang, Julie Vergara, Fabiano Oliveira, Randall F. Howard, Shaden Kamhawi, Dinesh Mondal, Rhea N. Coler, Jesus G. Valenzuela, Steven G. Reed
Format: Article
Language:English
Published: Nature Publishing Group 2017-08-01
Series:npj Vaccines
Online Access:https://doi.org/10.1038/s41541-017-0025-5